Application no. and date | 18770795.5 (espacenet) (Federated) (European Patent Register), 20180316 | Patent/reg. no. and date | DK/EP 3599892, 20240403 | Publication date | 20200205 | Priority no. and date | US 201762473763 P, 20170320 | EP pub. no. and date |
EP 3599892 20200205 | Effective date | | Applicant/owner | Bayer Healthcare LLC, 100 Bayer Boulevard P.O. Box 915
Whippany, NJ 07981-0915, US | Applicant ref. no. | | Inventor | SIRIHORACHAI, Rachan,
07981-0915 Whippany, US, BRADLEY, Reginald D.,
07981-0915 Whippany, US, ROSAR, Paul D.,
07981-0915 Whippany, US, EKPE, Anthony,
07981-0915 Whippany, US, JOSHI, Charu,
07981-0915 Whippany, US | Representative | | Opponent | | IPC Class | A23L 29/256 (2016.01) , A61K 31/4545 (2006.01) , A61K 47/36 (2006.01) , A61K 47/42 (2017.01) , A61K 9/00 (2006.01) , A61P 37/08 (2006.01) | Title | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Int. application no. | US2018023003 | Int. publication no. | WO2018175261 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|